Status:
COMPLETED
Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR)
Lead Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
The EMPOWeR study is proposed as a cohort study with longitudinal follow-up to determine rates of genetic mutations among men with or at-risk for prostate cancer to address the various facets of genet...
Eligibility Criteria
Inclusion
- Men with a personal history of prostate cancer
- Unaffected males who are at higher risk for prostate cancer (family history of prostate cancer or African American males)
- Men who previously tested positive for a mutation may be eligible for Specific Aims 2-7
- Men with a known familial mutation
- Men who previously participated in the Genetic Evaluation of Men (GEM) study (IRB#14S.546) will be offered participation in EMPOWeR -
Exclusion
- Age \< 18 years
- Mental or cognitive impairment that interferes with ability to provide informed consent
Key Trial Info
Start Date :
January 16 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 7 2024
Estimated Enrollment :
241 Patients enrolled
Trial Details
Trial ID
NCT03807492
Start Date
January 16 2019
End Date
February 7 2024
Last Update
May 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107